Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

1.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.8K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

1.0K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
1.0K
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

1.2K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-reported time toxicity with bispecific antibody therapies in relapsed/refractory follicular lymphoma and diffuse large B-cell lymphoma.

The oncologist·2026
Same author

Next-Generation Biomaterials for Neuroendovascular Devices: The Potential of Niobium, Tantalum, and Advanced Cobalt Alloys.

World neurosurgery·2026
Same author

Comparative evaluation of open flap debridement with or without injectable platelet-rich fibrin in chronic periodontitis treatment.

Bioinformation·2026
Same author

Knowledge, Attitude, and Awareness of Adolescents on the Emergency Management of Traumatic Dental Injuries.

Dentistry journal·2026
Same author

Molecular Pathways of Microbiota-derived Neuromodulation: An Integrative View.

Current neurovascular research·2026
Same author

Saving the split: An umbrella review on therapeutic approaches for cracked tooth syndrome.

Journal of conservative dentistry and endodontics·2026
Same journal

Real-World Evidence of Immunotherapy Sequencing in Multiple Myeloma: Durable Responses With BCMA-Targeting Bispecific Antibodies Following Prior GPRC5D-Targeting Therapy.

Clinical lymphoma, myeloma & leukemia·2026
Same journal

Clinical and Biological Implications of TP53 Abnormalities in Relapsed/Refractory Multiple Myeloma: The DEDALO Study.

Clinical lymphoma, myeloma & leukemia·2026
Same journal

Results of Third-Line Therapy in Philadelphia Chromosome-Positive Adult Acute Lymphoblastic Leukemia.

Clinical lymphoma, myeloma & leukemia·2026
Same journal

Potential Benefits and Harms of Screening Strategies for Monoclonal Gammopathy of Undetermined Significance in the US: A Simulation Study.

Clinical lymphoma, myeloma & leukemia·2026
Same journal

Impact of Treatment Sequencing With CAR T-cell Therapies and Bispecific Antibodies on Long-term Survival in 4L+ RRMM in the United States: A Simulation Model.

Clinical lymphoma, myeloma & leukemia·2026
Same journal

A Phase I Study of Copanlisib and Venetoclax in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Clinical lymphoma, myeloma & leukemia·2026
See all related articles

Related Experiment Video

Updated: Jul 23, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.2K

Plasmablastic Lymphoma: Past, Present, and Future.

Supreet Kaur1, Sudarsan Kollimuttathuillam2

  • 1University of Texas Health Science Center San Antonio, TX.

Clinical Lymphoma, Myeloma & Leukemia
|July 15, 2023
PubMed
Summary
This summary is machine-generated.

Plasmablastic Lymphoma, a rare aggressive B-cell lymphoma, is increasingly seen beyond HIV infection. This review covers its epidemiology, pathophysiology, markers, and treatments for this challenging disease.

Keywords:
BCMACARTDaratumumabHIVImmunotherapy

More Related Videos

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.7K
A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines
09:49

A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines

Published on: January 14, 2017

14.9K

Related Experiment Videos

Last Updated: Jul 23, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.2K
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.7K
A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines
09:49

A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines

Published on: January 14, 2017

14.9K

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Plasmablastic Lymphoma (PBL) is a rare, aggressive subtype of large B-cell lymphoma.
  • Historically linked to HIV infection, PBL now presents in various immunosuppressive conditions and immunocompetent individuals.

Purpose of the Study:

  • To provide a comprehensive review of Plasmablastic Lymphoma.
  • To consolidate current knowledge on epidemiology, pathophysiology, prognostic markers, and therapeutic strategies.

Main Methods:

  • Literature review of existing studies and clinical trials.
  • Synthesis of data on Plasmablastic Lymphoma characteristics and management.

Main Results:

  • PBL exhibits distinct immunohistochemical and morphological features.
  • The disease occurs across a spectrum of immune statuses, indicating evolving risk factors.
  • Outcomes remain generally unfavorable due to its aggressive nature.

Conclusions:

  • Plasmablastic Lymphoma requires a multidisciplinary approach for optimal management.
  • Further research into novel therapeutic targets and prognostic indicators is crucial for improving patient outcomes.